DISEASE RESISTANT GENETICS

DEAD

Serial Number

87437236

Owner

THE SEMEX ALLIANCE

Attorney

Maria A. Savio

Filing Date

May 4, 2017

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

DISEASE RESISTANT GENETICS Trademark

Serial Number: 87437236

DISEASE RESISTANT GENETICS is a trademark filed by THE SEMEX ALLIANCE on May 4, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 31 (Natural Agricultural Products), Class 35 (Advertising & Business). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Class 31 - Natural Agricultural Products

Raw and unprocessed agricultural, aquacultural, horticultural and forestry products

Class 35 - Advertising & Business

Advertising; business management; business administration; office functions

Owner Contact Info

THE SEMEX ALLIANCE (17 trademarks)

5653 Highway 6 North
GUELPH, ONTARIO N1H6J2 , CA

Entity Type: 13

Legal Representation

Attorney of Record

Maria A. Savio

1,371 trademarks filed View all →

Correspondence Address

MARIA A. SAVIO GOTTLIEB, RACKMAN & REISMAN, P.C.

270 MADISON AVE

8TH FLOOR

NEW YORK

NY 10016

Trademark Details

Filing Date

May 4, 2017

Registration Date

Not Registered

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Mar 2, 2020 MAB2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Mar 2, 2020 ABN2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

Aug 20, 2019 GNS2

INQUIRY TO SUSPENSION E-MAILED

Aug 20, 2019 GNSI

SUSPENSION INQUIRY WRITTEN

Aug 20, 2019 CNSI

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Feb 12, 2019 GNS3

LETTER OF SUSPENSION E-MAILED

Feb 12, 2019 GNSL

SUSPENSION LETTER WRITTEN

Feb 12, 2019 CNSL

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 12, 2019 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 12, 2019 CRFA

ASSIGNED TO LIE

Feb 7, 2019 ALIE

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

Feb 4, 2019 ERSI

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

Aug 6, 2018 GNS2

INQUIRY TO SUSPENSION E-MAILED

Aug 6, 2018 GNSI

SUSPENSION INQUIRY WRITTEN

Aug 6, 2018 CNSI

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Feb 5, 2018 GNS3

LETTER OF SUSPENSION E-MAILED

Feb 5, 2018 GNSL

SUSPENSION LETTER WRITTEN

Feb 5, 2018 CNSL

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 2, 2018 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 1, 2018 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 1, 2018 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Aug 1, 2017 GNRN

NON-FINAL ACTION E-MAILED

Aug 1, 2017 GNRT

NON-FINAL ACTION WRITTEN

Aug 1, 2017 CNRT

ASSIGNED TO EXAMINER

Aug 1, 2017 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 10, 2017 NWOS

NEW APPLICATION ENTERED

May 8, 2017 NWAP

Related Trademarks

More from this Owner

BOVITEQ

More in Same Class

ALPHA CREATINE

PREDNISOLONE SODIUM PHOSPHATE, GATIFLOXACIN OPHTHALMIC SOLUTION AND KETOROLAC TROMETHAMINE 1% / 0.5% / 0.5% OMNI BY OCULAR SCIENCE

FLORAVANI

PREDNISOLONE PO4 AND BROMFENAC SODIUM SESQUIHYDRATE 1% / 0.007% OMNI BY OCULAR SCIENCE

PREDNISOLONE PO4, GATIFLOXACIN, AND BROMFENAC SODIUM SESQUIHYDRATE 1% / 0.5%/ 0.007% OMNI BY OCULAR SCIENCE

NOWAY